May 1, 2025
119: The Testosterone Access Gap No One's Talking About
The player is loading ...
We need to talk about the glaring inequity in Australian healthcare that's affecting millions of women. After 18 months on menopause hormone therapy, testosterone has transformed my life, restoring my vitality, sharpening my focus, lifting my mood, and reawakening my sexuality. Yet accessing this life-changing treatment reveals a troubling gender bias in our healthcare system.
While nine testosterone products for men are subsidised through the PBS, Androfeme - the only female-specific testosterone cream in Australia - remains unsubsidised, costing women over $100 per script. This forces many of us to use male-formulated alternatives that require daily careful self-measurement, an imprecise and frustrating workaround that no woman should have to endure.
The numbers are staggering: an estimated 1.34 million Australian midlife women experience Hypoactive Sexual Desire Dysfunction (HSDD), yet face significant barriers to diagnosis and treatment.
Despite testosterone therapy being used safely and effectively for women since the 1940s, with Australian-made Androfemme recognised globally as a gold standard treatment, women continue to bear financial burdens that men don't face for essentially identical symptoms.
The solution is straightforward: include Androfemme on the PBS, just as other menopause treatments have recently been added.
Share this episode with friends, family, healthcare providers, and decision-makers.
Together, we can amplify women's voices and demand the equal treatment we deserve.
Women's health is not a luxury - it's time our healthcare system reflects that truth.
Links:
National Women's Health Advisory Council's Review
Testosterone has been treating women since 1940's
Testosterone for women: what you need to know
Thank you for listening to my show!
Join the conversation on Instagram
🤝 You can connect with Sonya here
💬 Send me a message here
❤️ Loved this episode? Share with a friend and don't forget to leave us a review and rating here
WEBVTT
00:00:01.564 --> 00:00:04.110
Welcome to the Dear Menopause podcast.
00:00:04.110 --> 00:00:06.777
I'm Sonya Lovell, your host Now.
00:00:06.777 --> 00:00:11.933
I've been bringing you conversations with amazing menopause experts for over two years now.
00:00:11.933 --> 00:00:21.126
If you have missed any of those conversations, now's the time to go back and listen, and you can always share them with anyone you think needs to hear them.
00:00:21.126 --> 00:00:25.783
This way, more people can find these amazing conversations, needs to hear them.
00:00:25.783 --> 00:00:27.004
This way, more people can find these amazing conversations.
00:00:27.024 --> 00:00:30.571
Hello and welcome to this week's episode of Dear Menopause.
00:00:30.571 --> 00:00:41.164
I am so glad that you are here, and today I have something a little bit different for you.
00:00:41.164 --> 00:00:42.067
I am recording a solo episode.
00:00:42.067 --> 00:00:50.752
I don't do this very often it's actually something that I'm not super comfortable doing but I have been on my soapbox recently and I decided that it was time that I recorded a bit of a podcast about it.
00:00:50.752 --> 00:01:05.915
So today I'm going to talk to you about something that's both deeply personal and deeply political Access to testosterone therapy for women in Australia, and why I believe it's time to change.
00:01:07.581 --> 00:01:18.992
So when I first started taking my menopause hormone therapy, which is about 18 months ago now, one of the most significant and transformative parts of my treatment has been testosterone.
00:01:18.992 --> 00:01:21.483
It has given me back a sense of vitality.
00:01:21.483 --> 00:01:24.329
It's absolutely improved my focus.
00:01:24.329 --> 00:01:33.414
It's definitely lifted my mood and, honestly, it helped reawaken a part of me that I thought was gone forever, and that was my sex life.
00:01:33.414 --> 00:01:49.081
But, like so many women across Australia, I very quickly discovered that accessing a testosterone product designed specifically for women is anything but straightforward or, more importantly, affordable.
00:01:49.081 --> 00:02:00.506
Now I use testosterone every day, but not the formulation that is made specifically for women by an Australian company.
00:02:00.506 --> 00:02:01.346
Why?
00:02:01.346 --> 00:02:08.722
Because the only female specific testosterone cream, which is called Androfeme, is expensive.
00:02:08.722 --> 00:02:23.711
It's not on the PBS, so it has to come on a private script, which means that it is over $100 per script and it's simply not sustainable long-term for many women, and that includes me.
00:02:23.711 --> 00:02:28.703
So instead I use a product that's designed for men.
00:02:28.703 --> 00:02:42.383
It's financially accessible because it's available on the PBS, but using a male-formulated product means that I have to carefully apportion a dose every day that's appropriate for my female body.
00:02:42.383 --> 00:02:49.814
Yep, every single time I use it, I have to self-measure how much I'm applying.
00:02:49.814 --> 00:02:58.103
It's not ideal and it's not what I would choose if cost wasn't a factor, but it's the reality that many others face.
00:02:58.383 --> 00:03:02.073
So, as I said at the beginning, this isn't just my personal story.
00:03:02.073 --> 00:03:08.840
This is a systemic issue, because let's talk about what's really going on here.
00:03:08.840 --> 00:03:12.187
This is a case of gendered inequity.
00:03:12.187 --> 00:03:32.867
So the National Women's Health Advisory Council recently reviewed what so many of us already know, and that is that sex and gender imbalances in our healthcare system are ongoing and widespread, and testosterone access is just one prime example.
00:03:32.867 --> 00:03:34.632
Let this sit with you for a moment.
00:03:34.632 --> 00:03:51.612
Currently, there are nine testosterone products for men subsidized through the PBS Nine, and yet Androfem, the only TGA-approved testosterone therapy for women, remains excluded.
00:03:51.612 --> 00:03:58.092
The result it's a financial burden which is borne solely by women.
00:03:58.092 --> 00:04:03.332
It is, in my books, a textbook case of gender bias in healthcare policy.
00:04:03.580 --> 00:04:19.656
Treatments for essentially the same symptoms low libido and related distress because they are the only symptoms that testosterone is approved to be prescribed to women for are funded for men but not for women.
00:04:19.656 --> 00:04:26.749
Honestly, the imbalance is indefensible and, frankly, it's infuriating.
00:04:26.749 --> 00:04:32.562
Indefensible and frankly, it's infuriating.
00:04:32.562 --> 00:04:41.625
So let's talk for a moment what I just mentioned there, which was that low libido and related stress are the only conditions that testosterone is approved to be prescribed for.
00:04:41.625 --> 00:04:53.826
It's actually a condition called HSDD, and let's talk about why it matters that women who do suffer from HSDD have equitable access to testosterone.
00:04:53.826 --> 00:05:01.423
So hypoactive sexual desire dysfunction is a diagnosable medical condition.
00:05:01.423 --> 00:05:13.029
It's marked by a persistently low libido that causes significant personal distress, and it impacts far more than just sex.
00:05:13.029 --> 00:05:19.874
It affects a woman's overall well-being, her mental health, her relationships and her self-esteem.
00:05:21.399 --> 00:05:32.880
So I did a bit of digging and, using data from an Australian study on HSDD combined with some current ABS statistics, I did some math.
00:05:32.880 --> 00:05:44.264
And the results an estimated 1.34 million midlife Australian women are currently experiencing symptoms of HSDD.
00:05:44.264 --> 00:05:59.874
But here's the thing Based on the countless conversations I've had with friends, podcast listeners and clinicians, I truly believe that the real number is even higher.
00:05:59.874 --> 00:06:02.182
Study from 27,.
00:06:02.182 --> 00:06:15.704
Sorry, the study from 2017 reported 32.2% of midlife women were affected, but today I would argue that that is much closer to 50%.
00:06:15.704 --> 00:06:25.846
And yet, despite these numbers, very few women ever receive a formal diagnosis, let alone treatment.
00:06:25.846 --> 00:06:27.569
And why?
00:06:27.569 --> 00:06:37.516
Because of stigma, because of under-recognition of the condition and because of the significant cost barriers standing in the way.
00:06:39.220 --> 00:07:00.232
Testosterone therapy has been used safely and effectively to treat low libido in women since the 1940s, and Androfeme, which is made right here in Australia, is globally recognized as a gold standard product specifically formulated for women.
00:07:00.232 --> 00:07:07.776
So why, in 2025, is Androfeme still not on the PBS?
00:07:07.776 --> 00:07:13.949
Australian women are being left behind in our own backyard.
00:07:13.949 --> 00:07:17.956
Now look, I'm not asking for special treatment.
00:07:17.956 --> 00:07:21.343
I'm asking for equal treatment.
00:07:21.343 --> 00:07:34.992
If testosterone is subsidized for men experiencing low libido, even when it doesn't meet the strict criteria of HSTD, then women deserve the same support for the same issue.
00:07:34.992 --> 00:07:46.380
Anything less is just another example of outdated patriarchal thinking that has played women's health for far too long Now.
00:07:46.560 --> 00:07:48.927
I believe the solution here is simple.
00:07:48.927 --> 00:08:06.076
The Australian government must support the inclusion of androfem on the PBS, the same way that it has recently supported the inclusion of Prometrium and Estrogel, and Estrogel Pro and also Slinder.
00:08:06.076 --> 00:08:23.742
And when they support the inclusion of Androfeme, they will remove the financial barrier to treatment for hundreds of thousands of Australian women, and they'll also be supporting an Australian company that creates jobs and manufactures locally.
00:08:23.742 --> 00:08:28.848
They'll align our health policy with both evidence and international progress.
00:08:28.848 --> 00:08:37.092
And look, most importantly, it sends a really clear message that women's sexual health matters and it's worth funding.
00:08:37.092 --> 00:08:41.386
Women's health deserves equality.
00:08:41.386 --> 00:08:44.433
Our well-being is not a luxury.
00:08:45.600 --> 00:08:56.299
Treatment of testosterone has changed my life for the better, but accessing it shouldn't require a male-oriented workaround.
00:08:56.299 --> 00:09:12.977
I also want to touch, before I wrap this up, on the fact that testosterone for women can also be prescribed for many symptoms of perimenopause and menopause that go beyond low libido and HSDD.
00:09:12.977 --> 00:09:22.182
I mentioned right at the very beginning that I have definitely benefited from impacts to my vitality, my cognitive clarity.
00:09:22.182 --> 00:09:27.261
I had a beautiful friend recently say that it was like it put the color back into her life.
00:09:27.261 --> 00:09:47.481
So, yes, testosterone is prescribed for HSDD, low libido and sexual desire, but it can also be prescribed for many other symptoms and side effects of perimenopause and menopause.
00:09:47.481 --> 00:09:54.648
It's time for the PBS to catch up with the reality of women's needs and to give us the equal access that we deserve.
00:09:54.648 --> 00:09:57.174
Thank you so much for listening.
00:09:57.174 --> 00:10:07.231
If this episode resonated with you or if you want to be a part of Pushing for Change, please share it with your friends, your family, your doctors and your networks.
00:10:07.231 --> 00:10:10.863
Let's make sure that women's voices are heard.
00:10:10.863 --> 00:10:13.711
Until next time, take care.
00:00:01.564 --> 00:00:04.110
00:00:04.110 --> 00:00:06.777
00:00:06.777 --> 00:00:11.933
00:00:11.933 --> 00:00:21.126
00:00:21.126 --> 00:00:25.783
00:00:25.783 --> 00:00:27.004
00:00:27.024 --> 00:00:30.571
00:00:30.571 --> 00:00:41.164
00:00:41.164 --> 00:00:42.067
00:00:42.067 --> 00:00:50.752
00:00:50.752 --> 00:01:05.915
00:01:07.581 --> 00:01:18.992
00:01:18.992 --> 00:01:21.483
00:01:21.483 --> 00:01:24.329
00:01:24.329 --> 00:01:33.414
00:01:33.414 --> 00:01:49.081
00:01:49.081 --> 00:02:00.506
00:02:00.506 --> 00:02:01.346
00:02:01.346 --> 00:02:08.722
00:02:08.722 --> 00:02:23.711
00:02:23.711 --> 00:02:28.703
00:02:28.703 --> 00:02:42.383
00:02:42.383 --> 00:02:49.814
00:02:49.814 --> 00:02:58.103
00:02:58.383 --> 00:03:02.073
00:03:02.073 --> 00:03:08.840
00:03:08.840 --> 00:03:12.187
00:03:12.187 --> 00:03:32.867
00:03:32.867 --> 00:03:34.632
00:03:34.632 --> 00:03:51.612
00:03:51.612 --> 00:03:58.092
00:03:58.092 --> 00:04:03.332
00:04:03.580 --> 00:04:19.656
00:04:19.656 --> 00:04:26.749
00:04:26.749 --> 00:04:32.562
00:04:32.562 --> 00:04:41.625
00:04:41.625 --> 00:04:53.826
00:04:53.826 --> 00:05:01.423
00:05:01.423 --> 00:05:13.029
00:05:13.029 --> 00:05:19.874
00:05:21.399 --> 00:05:32.880
00:05:32.880 --> 00:05:44.264
00:05:44.264 --> 00:05:59.874
00:05:59.874 --> 00:06:02.182
00:06:02.182 --> 00:06:15.704
00:06:15.704 --> 00:06:25.846
00:06:25.846 --> 00:06:27.569
00:06:27.569 --> 00:06:37.516
00:06:39.220 --> 00:07:00.232
00:07:00.232 --> 00:07:07.776
00:07:07.776 --> 00:07:13.949
00:07:13.949 --> 00:07:17.956
00:07:17.956 --> 00:07:21.343
00:07:21.343 --> 00:07:34.992
00:07:34.992 --> 00:07:46.380
00:07:46.560 --> 00:07:48.927
00:07:48.927 --> 00:08:06.076
00:08:06.076 --> 00:08:23.742
00:08:23.742 --> 00:08:28.848
00:08:28.848 --> 00:08:37.092
00:08:37.092 --> 00:08:41.386
00:08:41.386 --> 00:08:44.433
00:08:45.600 --> 00:08:56.299
00:08:56.299 --> 00:09:12.977
00:09:12.977 --> 00:09:22.182
00:09:22.182 --> 00:09:27.261
00:09:27.261 --> 00:09:47.481
00:09:47.481 --> 00:09:54.648
00:09:54.648 --> 00:09:57.174
00:09:57.174 --> 00:10:07.231
00:10:07.231 --> 00:10:10.863
00:10:10.863 --> 00:10:13.711
